References
- Burden of COPD, chronic respiratory pulmonary disease. WHO. Available at: http://www.who.int/respiratory/copd/burden/en/[Last accessed 18 April 2016]
- Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008;63:831-8
- Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 2008;3:371-84
- Vestbo J, Anderson JA, Calverley PMA, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009;64:939-43
- Lavorini F. The challenge of delivering therapeutic aerosols to asthma patients. ISRN Allergy 2013:102418
- Anderson P. Patient preference for and satisfaction with inhaler devices. Eur Respir Rev 2005;14:109-16
- Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med 2000;94:496-500
- Hodder R, Price D. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat soft mist inhaler. Int J Chron Obstruct Pulmon Dis 2009;4:381-90
- Schürmann W, Schmidtmann S, Moroni P, et al. Respimat soft mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction. Treat Respir Med 2005;4:53-61
- Davis K, Su J, González J, et al. Assessment of patient satisfaction and preference of inhaler attributes in patients using combivent respimat. Poster presented at the Academy of Managed Care Pharmacy 2014 Nexus Conference. Boston, 2014
- Ganderton D. Targeted delivery of inhaled drugs: current challenges and future goals. J Aerosol Med Off J Int Soc Aerosols Med 1999;12(Suppl1):S3-S8
- Johnson R, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health 2013;16:3-13
- Ryan M, Hughes J. Using conjoint analysis to assess women’s preferences for miscarriage management. Health Econ 1997;6:261-73
- Jendle J, Torffvit O, Ridderstråle M, et al. Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes. Curr Med Res Opin 2010;26:917-23
- Lancaster K. Consumer Demand: A New Approach. Economic Association, Columbia University Press, Columbia, 1971
- Barker N. A Practical Introduction to the Bootstrap Using the SAS System. Oxford Pharmaceutical Sciences, 2005
- Vincken W, Dekhuijzen PR, Barnes P; ADMIT Group. The ADMIT series – issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD. Prim Care Respir J J Gen Pract Airw Group 2010;19:10-12
- Louviere J, Timmermans H. Stated preferences and choice models applied to recreation research: a review. Leis Sci 1990;12:9-32
- Beulen L, Grutters JPC, Faas BHW, et al. Women’s and healthcare professionals’ preferences for prenatal testing: a discrete choice experiment. Prenat Diagn 2015;35:549-57
- Boone D, Mallett S, Zhu S, et al. Patients’ & healthcare professionals’ values regarding true- & false-positive diagnosis when colorectal cancer screening by CT colonography: discrete choice experiment. PLoS One 2013;8:e80767
- Payne K, Fargher EA, Roberts SA, et al. Valuing pharmacogenetic testing services: a comparison of patients’ and health care professionals’ preferences. Value Health J Int Soc Pharmacoeconomics Outcomes Res 2011;14:121-34
- Deal K, Keshavjee K, Troyan S, et al. Physician and patient willingness to pay for electronic cardiovascular disease management. Int J Med Inf 2014;83:517-28
- Lee A, Gin T, Lau ASC, Ng FF. A comparison of patients’ and health care professionals’ preferences for symptoms during immediate postoperative recovery and the management of postoperative nausea and vomiting. Anesth Analg 2005;100:87-93